• 19604 Citations
  • 72 Scopus h-Index
1976 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2020

A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors

Zhu, M., Molina, J. R., Dy, G. K., Croghan, G. A., Qi, Y., Glockner, J., Hanson, L. J., Roos, M. M., Tan, A. D. & Adjei, A. A., Jan 1 2020, (Accepted/In press) In : Investigational New Drugs.

Research output: Contribution to journalArticle

Influence of Sociodemographic Factors on Treatment Decisions in Non–Small-Cell Lung Cancer

Duma, N., Idossa, D. W., Durani, U., Frank, R. D., Paludo, J., Westin, G., Lou, Y., Mansfield, A. S., Adjei, A. A., Go, R. S. & Ailawadhi, S., May 2020, In : Clinical lung cancer. 21, 3, p. e115-e129

Research output: Contribution to journalArticle

Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal Specimens

Parikh, K., Huether, R., White, K., Hoskinson, D., Beaubier, N., Dong, H., Adjei, A. A. & Mansfield, A. S., Feb 5 2020, In : JAMA Network Open. 3, 2, p. e200202

Research output: Contribution to journalArticle

Open Access
2019

5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study

Luo, Y. H., Luo, L., Wampfler, J. A., Wang, Y., Liu, D., Chen, Y. M., Adjei, A., Midthun, D. E. & Yang, P., Aug 1 2019, In : The Lancet Oncology. 20, 8, p. 1098-1108 11 p.

Research output: Contribution to journalArticle

Open Access
4 Scopus citations

A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance)

Parikh, K., Mandrekar, S. J., Allen-Ziegler, K., Esplin, B., Tan, A. D., Marchello, B., Adjei, A. A. & Molina, J. R., Jan 1 2019, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma

Xie, H., Yin, J., Shah, M. H., Menefee, M. E., Bible, K. C., Reidy-Lagunes, D., Kane, M. A., Quinn, D. I., Gandara, D. R., Erlichman, C. & Adjei, A., Jan 1 2019, In : Investigational New Drugs.

Research output: Contribution to journalArticle

2 Scopus citations
1 Scopus citations

Pathologic Considerations and Standardization in Mesothelioma Clinical Trials

Tsao, M. S., Carbone, M., Galateau-Salle, F., Moreira, A. L., Nicholson, A. G., Roden, A. C., Adjei, A. A., Aubry, M. C., Fennell, D. A., Gomez, D., Harpole, D., Hesdorffer, M., Hirsch, F. R., Liu, G., Malik, S., Nowak, A., Peikert, T., Salgia, R., Szlosarek, P., Taioli, E. & 3 others, Yang, H., Tsao, A. & Mansfield, A. S., Oct 2019, In : Journal of Thoracic Oncology. 14, 10, p. 1704-1717 14 p.

Research output: Contribution to journalArticle

1 Scopus citations

Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee – International Association for the Study of Lung Cancer – Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting

Gill, R. R., Tsao, A. S., Kindler, H. L., Richards, W. G., Armato, S. G., Francis, R. J., Gomez, D. R., Dahlberg, S., Rimner, A., Simone, C. B., de Perrot, M., Blumenthal, G., Adjei, A. A., Bueno, R., Harpole, D. H., Hesdorffer, M., Hirsch, F. R., Pass, H. I., Yorke, E., Rosenzweig, K. & 10 others, Burt, B., Fennell, D. A., Lindwasser, W., Malik, S., Peikert, T., Mansfield, A. S., Salgia, R., Yang, H., Rusch, V. W. & Nowak, A. K., Oct 2019, In : Journal of Thoracic Oncology. 14, 10, p. 1718-1731 14 p.

Research output: Contribution to journalArticle

Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?

Duma, N., Abdel-Ghani, A., Yadav, S., Hoversten, K. P., Reed, C. T., Sitek, A. N., Enninga, E. A. L., Paludo, J., Aguilera, J. V., Leventakos, K., Lou, Y., Kottschade, L. A., Dong, H. M., Mansfield, A., Manochakian, R., Adjei, A. & Dronca, R. S., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalArticle

6 Scopus citations
2018

A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib with Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients

Ma, W. W., Xie, H., Fetterly, G., Pitzonka, L., Whitworth, A., Levea, C., Wilton, J., Mantione, K., Schihl, S., Dy, G. K., Boland, P., Iyer, R., Tan, W., Brady, W., Straubinger, R. M. & Adjei, A., Jan 1 2018, (Accepted/In press) In : American Journal of Clinical Oncology: Cancer Clinical Trials.

Research output: Contribution to journalArticle

2 Scopus citations

A phase II clinical trial of veliparib and topotecan in patients with platinum resistant ovarian cancer

Wahner Hendrickson, A. E., Costello, B., Jewell, A., Kennedy, V., Fleming, G., Corr, B., Taylor, S. E., Lea, J., Reid, J., Swisher, E., Satele, D., Allred, J., Lensing, J., Ivy, S. P., Erlichman, C., Adjei, A. A. & Kaufmann, S., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii357

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Association between hospital volume and mortality of patients with metastatic non-small cell lung cancer

Goyal, G., Kommalapati, A., Bartley, A. C., Gunderson, T. M., Adjei, A. & Go, R. S., Aug 1 2018, In : Lung Cancer. 122, p. 214-219 6 p.

Research output: Contribution to journalArticle

2 Scopus citations

Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation

Tsao, A. S., Lindwasser, O. W., Adjei, A. A., Adusumilli, P. S., Beyers, M. L., Blumenthal, G. M., Bueno, R., Burt, B. M., Carbone, M., Dahlberg, S. E., de Perrot, M., Fennell, D. A., Friedberg, J., Gill, R. R., Gomez, D. R., Harpole, D. H., Hassan, R., Hesdorffer, M., Hirsch, F. R., Hmeljak, J. & 21 others, Kindler, H. L., Korn, E. L., Liu, G., Mansfield, A. S., Nowak, A. K., Pass, H. I., Peikert, T., Rimner, A., Robinson, B. W. S., Rosenzweig, K. E., Rusch, V. W., Salgia, R., Sepesi, B., Simone, C. B., Sridhara, R., Szlosarek, P., Taioli, E., Tsao, M. S., Yang, H., Zauderer, M. G. & Malik, S. M., Nov 2018, In : Journal of Thoracic Oncology. 13, 11, p. 1655-1667 13 p.

Research output: Contribution to journalArticle

23 Scopus citations

CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy

Yan, Y., Cao, S., Liu, X., Harrington, S. M., Bindeman, W. E., Adjei, A. A., Jang, J. S., Jen, J., Li, Y., Chanana, P., Mansfield, A. S., Park, S. S., Markovic, S. N., Dronca, R. S. & Dong, H., Apr 19 2018, In : JCI insight. 3, 8

Research output: Contribution to journalArticle

Open Access
16 Scopus citations

Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors

Moschos, S. J., Sullivan, R. J., Hwu, W. J., Ramanathan, R. K., Adjei, A. A., Fong, P. C., Shapira-Frommer, R., Tawbi, H. A., Rubino, J., Rush, T. S., Zhang, D., Miselis, N. R., Samatar, A. A., Chun, P., Rubin, E. H., Schiller, J., Long, B. J., Dayananth, P., Carr, D., Kirschmeier, P. & 8 others, Bishop, W. R., Deng, Y., Cooper, A., Shipps, G. W., Moreno, B. H., Robert, L., Ribas, A. & Flaherty, K. T., Feb 22 2018, In : JCI Insight. 3, 4

Research output: Contribution to journalArticle

Open Access
27 Scopus citations

Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies

Soyano, A. E., Dholaria, B., Marin-Acevedo, J. A., Diehl, N., Hodge, D., Luo, Y., Manochakian, R., Chumsri, S., Adjei, A., Knutson, K. L. & Lou, Y., Nov 23 2018, In : Journal for ImmunoTherapy of Cancer. 6, 1, 129.

Research output: Contribution to journalArticle

20 Scopus citations

Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centers

Lou, Y., Dholaria, B., Soyano, A., Hodge, D., Cochuyt, J., Manochakian, R., Ko, S. J., Thomas, M., Johnson, M., Patel, N. M., Miller, R. C., Adjei, A. & Ailawadhi, S., Jan 1 2018, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

5 Scopus citations

What is a “High-Impact” Journal?

Adjei, A., Jan 1 2018, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

2017
38 Scopus citations

A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non–small cell lung cancer

Soria, J. C., Adjei, A., Bahleda, R., Besse, B., Ferte, C., Planchard, D., Zhou, J., Ware, J., Morrissey, K., Shankar, G., Lin, W., Schutzman, J. L., Dy, G. K. & Groen, H. J. M., Nov 1 2017, In : European Journal of Cancer. 86, p. 186-196 11 p.

Research output: Contribution to journalArticle

7 Scopus citations

A phase I clinical trial and independent patient-derived xenograft study of combined targeted treatment with dacomitinib and figitumumab in advanced solid tumors

Calvo, E., Soria, J. C., Ma, W. W., Wang, T., Bahleda, R., Tolcher, A. W., Gernhardt, D., O'Connell, J., Millham, R., Giri, N., Wick, M. J., Adjei, A. & Hidalgo, M., Mar 1 2017, In : Clinical Cancer Research. 23, 5, p. 1177-1185 9 p.

Research output: Contribution to journalArticle

13 Scopus citations

A phase I dose-escalation study of TAK-733, an investigational oral MEK inhibitor, in patients with advanced solid tumors

Adjei, A. A., LoRusso, P., Ribas, A., Sosman, J. A., Pavlick, A., Dy, G. K., Zhou, X., Gangolli, E., Kneissl, M., Faucette, S., Neuwirth, R. & Bózon, V., Feb 1 2017, In : Investigational New Drugs. 35, 1, p. 47-58 12 p.

Research output: Contribution to journalArticle

11 Scopus citations

First-in-human phase I Study of the tamoxifen metabolite Z-endoxifen in women with endocrine-refractory metastatic breast cancer

Goetz, M. P., Suman, V. J., Reid, J. M., Northfelt, D. W., Mahr, M. A., Ralya, A. T., Kuffel, M., Visscher, S. A., Kipp, B. R., Liu, M. C., Hawse, J. R., Ames, M. M., Ingle Buhrow, J. N., Safgren, S. L., McGovern, R. M., Black, J., Dockter, T., Haddad, T. C., Erlichman, C., Adjei, A. & 7 others, Collins, D., Streicher, H., Chalmers, Z. R., Frampton, G., Hawse, J. R., Doroshow, J. H. & Collins, J. M., Oct 20 2017, In : Journal of Clinical Oncology. 35, 30, p. 3391-3400 10 p.

Research output: Contribution to journalArticle

27 Scopus citations

Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non–Small Cell Lung Cancer: NCCTG N0028 (Alliance)

Mayo Clinic, North Central Cancer Treatment Group, Apr 1 2017, In : Journal of Thoracic Oncology. 12, 4, p. 697-703 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

Management of Multifocal Lung Cancer: Results of a Survey

Leventakos, K., Peikert, T. D., Midthun, D. E., Molina, J. R., Blackmon, S., Nichols, F. C., Garces, Y. I., Hallemeier, C., Murphy, S. J., Vasmatzis, G., Kratz, S. L., Holland, W. P., Thomas, C. F., Mullon, J. J., Shen, K. R., Cassivi, S. D., Marks, R. S., Aubry, M. C., Adjei, A., Yang, P. & 4 others, Allen, M. S., Edell, E., Wigle, D. A. & Mansfield, A., 2017, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

8 Scopus citations

Quality-of-life (QOL) during screening for phase 1 trial studies in patients with advanced solid tumors and its impact on risk for serious adverse events

Anwar, S., Tan, W., Hong, C. C., Admane, S., Dozier, A., Siedlecki, F., Whitworth, A., Diraddo, A. M., DePaolo, D., Jacob, S. M., Ma, W. W., Miller, A., Adjei, A. & Dy, G. K., Jul 1 2017, In : Cancers. 9, 7, 73.

Research output: Contribution to journalArticle

3 Scopus citations

Validation of progression-free survival as a surrogate endpoint for overall survival inmalignant mesothelioma: Analysis of cancer and leukemia group B and north central cancer treatment group (Alliance) trials

Wang, X., Wang, X., Hodgson, L., George, S. L., Sargent, D. J., Foster, N. R., Ganti, A. K., Stinchcombe, T. E., Crawford, J., Kratzke, R., Adjei, A., Kindler, H. L., Vokes, E. E. & Pang, H., Feb 10 2017, In : Oncologist. 22, 2, p. 189-198 10 p.

Research output: Contribution to journalArticle

3 Scopus citations
2016

A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors

Rosen, L. S., LoRusso, P., Ma, W. W., Goldman, J. W., Weise, A., Colevas, A. D., Adjei, A., Yazji, S., Shen, A., Johnston, S., Hsieh, H. J., Chan, I. T. & Sikic, B. I., Oct 1 2016, In : Investigational New Drugs. 34, 5, p. 604-613 10 p.

Research output: Contribution to journalArticle

23 Scopus citations

A phase I study of the safety, Pharmacokinetics, and Pharmacodynamics of combination therapy with refametinib plus sorafenib in patients with advanced cancer

Adjei, A., Richards, D. A., El-Khoueiry, A., Braiteh, F., Becerra, C. H. R., Jr, J. J. S., Hezel, A. F., Sherman, M., Garbo, L., Leffingwell, D. P., Iverson, C., Miner, J. N., Shen, Z., Yeh, L. T., Gunawan, S., Wilson, D. M., Manhard, K. J., Rajagopalan, P., Krissel, H. & Clendeninn, N. J., May 15 2016, In : Clinical Cancer Research. 22, 10, p. 2368-2376 9 p.

Research output: Contribution to journalArticle

7 Scopus citations

Consensus report of the 2015 Weinman international conference on mesothelioma

Carbone, M., Kanodia, S., Chao, A., Miller, A., Wali, A., Weissman, D., Adjei, A., Baumann, F., Boffetta, P., Buck, B., De Perrot, M., Dogan, A. U., Gavett, S., Gualtieri, A., Hassan, R., Hesdorffer, M., Hirsch, F. R., Larson, D., Mao, W., Masten, S. & 8 others, Pass, H. I., Peto, J., Pira, E., Steele, I., Tsao, A., Woodard, G. A., Yang, H. & Malik, S., Jan 1 2016, In : Journal of Thoracic Oncology. 11, 8, p. 1246-1262 17 p.

Research output: Contribution to journalArticle

76 Scopus citations

Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways

Zhang, H., Shao, H., Golubovskaya, V. M., Chen, H., Cance, W., Adjei, A. & Dy, G. K., Jul 12 2016, In : British Journal of Cancer. 115, 2, p. 203-211 9 p.

Research output: Contribution to journalArticle

11 Scopus citations

Enrollment trends and disparity among patients with lung cancer in national clinical trials, 1990 to 2012

Pang, H. H., Wang, X., Stinchcombe, T. E., Wong, M. L., Cheng, P., Ganti, A. K., Sargent, D. J., Zhang, Y., Hu, C., Mandrekar, S. J., Redman, M. W., Manola, J. B., Schilsky, R. L., Cohen, H. J., Bradley, J. D., Adjei, A., Gandara, D., Ramalingam, S. S. & Vokes, E. E., Nov 20 2016, In : Journal of Clinical Oncology. 34, 33, p. 3992-3999 8 p.

Research output: Contribution to journalArticle

34 Scopus citations

MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations

Arena, S., Siravegna, G., Mussolin, B., Kearns, J. D., Wolf, B. B., Misale, S., Lazzari, L., Bertotti, A., Trusolino, L., Adjei, A. A., Montagut, C., Di Nicolantonio, F., Nering, R. & Bardelli, A., Feb 3 2016, In : Science translational medicine. 8, 324, 324ra14.

Research output: Contribution to journalArticle

51 Scopus citations
2015

2nd ESMO Consensus Conference in Lung Cancer: Locally advanced stage III non-small-cell lung cancer

Panel Members, Jan 1 2015, In : Annals of Oncology. 26, 8, p. 1573-1588 16 p.

Research output: Contribution to journalArticle

167 Scopus citations

A phase i study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors

Ngamphaiboon, N., Dy, G. K., Ma, W. W., Zhao, Y., Reungwetwattana, T., Depaolo, D., Ding, Y., Brady, W., Fetterly, G. & Adjei, A. A., Feb 2015, In : Investigational New Drugs. 33, 1, p. 225-232 8 p.

Research output: Contribution to journalArticle

20 Scopus citations

APhase i study of the SMAC-mimetic birinapant in adults with refractory solid tumorsor lymphoma

Amaravadi, R. K., Schilder, R. J., Martin, L. P., Levin, M., Graham, M. A., Weng, D. E. & Adjei, A. A., Nov 1 2015, In : Molecular cancer therapeutics. 14, 11, p. 2569-2575 7 p.

Research output: Contribution to journalArticle

45 Scopus citations

Lung cancer and metastasis: new opportunities and challenges

Wang, X. & Adjei, A., Jun 1 2015, In : Cancer and Metastasis Reviews. 34, 2, p. 169-171 3 p.

Research output: Contribution to journalArticle

25 Scopus citations

Multitrial evaluation of progression-free survival as a surrogate end point for overall survival in first-line extensive-stage small-cell lung cancer

Foster, N. R., Renfro, L. A., Schild, S. E., Redman, M. W., Wang, X. F., Dahlberg, S. E., Ding, K., Bradbury, P. A., Ramalingam, S. S., Gandara, D. R., Shibata, T., Saijo, N., Vokes, E. E., Adjei, A. & Mandrekar, S. J., Jul 4 2015, In : Journal of Thoracic Oncology. 10, 7, p. 1099-1106 8 p.

Research output: Contribution to journalArticle

20 Scopus citations

New strategies to develop new medications for lung cancer and metastasis

Zhao, Y. & Adjei, A., Jun 1 2015, In : Cancer and Metastasis Reviews. 34, 2, p. 265-275 11 p.

Research output: Contribution to journalArticle

7 Scopus citations

Phase 1b study of the oral gemcitabine 'Pro-drug' LY2334737 in combination with capecitabine in patients with advanced solid tumors

Infante, J. R., Benhadji, K. A., Dy, G. K., Fetterly, G., Ma, W. W., Bendell, J., Callies, S. & Adjei, A., Apr 1 2015, In : Investigational New Drugs. 33, 2, p. 432-439 8 p.

Research output: Contribution to journalArticle

7 Scopus citations

Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors

Puzanov, I., Sosman, J., Santoro, A., Saif, M. W., Goff, L., Dy, G. K., Zucali, P., Means-Powell, J. A., Ma, W. W., Simonelli, M., Martell, R., Chai, F., Lamar, M., Savage, R. E., Schwartz, B. & Adjei, A. A., Feb 2015, In : Investigational New Drugs. 33, 1, p. 159-168 10 p.

Research output: Contribution to journalArticle

30 Scopus citations

Targeting angiogenesis in cancer therapy: Moving beyond vascular endothelial growth factor

Zhao, Y. & Adjei, A., Jan 1 2015, In : Oncologist. 20, 6, p. 660-673 14 p.

Research output: Contribution to journalArticle

203 Scopus citations
2014

2nd ESMO consensus conference on lung cancer: Early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

Vansteenkiste, J., Crinò, L., Dooms, C., Douillard, J. Y., Faivre-Finn, C., Lim, E., Rocco, G., Senan, S., van Schil, P., Veronesi, G., Stahel, R., Peters, S., Felip, E., Kerr, K., Besse, B., Eberhardt, W., Edelman, M., Mok, T., O'Byrne, K., Novello, S. & 15 others, Bubendorf, L., Marchetti, A., Baas, P., Reck, M., Syrigos, K., Paz-Ares, L., Smit, E. F., Meldgaard, P., Adjei, A., Nicolson, M., Weder, W., de Ruysscher, D., Le Pechoux, C., de Leyn, P. & Westeel, V., Aug 2014, In : Annals of Oncology. 25, 8, p. 1462-1474 13 p., mdu089.

Research output: Contribution to journalArticle

200 Scopus citations

2nd ESMO Consensus Conference on Lung Cancer: Non-small-cell lung cancer first-line/second and further lines in advanced disease

Besse, B., Adjei, A., Baas, P., Meldgaard, P., Nicolson, M., Paz-Ares, L., Reck, M., Smit, E. F., Syrigos, K., Stahel, R., Felip, E., Peters, S., Stahel, R., Felip, E., Peters, S., Kerr, K., Besse, B., Vansteenkiste, J., Eberhardt, W., Edelman, M. & 27 others, Mok, T., O'Byrne, K., Novello, S., Bubendorf, L., Marchetti, A., Baas, P., Reck, M., Syrigos, K., Paz-Ares, L., Smit, E. F., Meldgaard, P., Adjei, A., Nicolson, M., Crinò, L., Van Schil, P., Senan, S., Faivre-Finn, C., Rocco, G., Veronesi, G., Douillard, J. Y., Lim, E., Dooms, C., Weder, W., De Ruysscher, D., Le Pechoux, C., De Leyn, P. & Westeel, V., Aug 2014, In : Annals of Oncology. 25, 8, p. 1475-1484 10 p., mdu123.

Research output: Contribution to journalArticle

143 Scopus citations

A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin and Concurrent Thoracic Radiation Therapy for Non-Small Cell Lung Cancer: NCCTG-N0321

Zhao, Y., Foster, N. R., Meyers, J. P., Thomas, S. P., Northfelt, D. W., Rowland, K. M., Mattar, B. I., Johnson, D. B., Molina, J. R., Mandrekar, S. J., Schild, S. E., Bearden, J. D., Aubry, M. C. & Adjei, A., Sep 22 2014, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

21 Scopus citations

A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer

Chen, H., Modiano, M. R., Neal, J. W., Brahmer, J. R., Rigas, J. R., Jotte, R. M., Leighl, N. B., Riess, J. W., Kuo, C. J., Liu, L., Gao, B., Dicioccio, A. T., Adjei, A. A. & Wakelee, H. A., Feb 4 2014, In : British journal of cancer. 110, 3, p. 602-608 7 p.

Research output: Contribution to journalArticle

19 Scopus citations

A phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621

Molina, J. R., Foster, N. R., Reungwetwattana, T., Nelson, G. D., Grainger, A. V., Steen, P. D., Stella, P. J., Marks, R., Wright, J. & Adjei, A. A., Aug 2014, In : Lung Cancer. 85, 2, p. 245-250 6 p.

Research output: Contribution to journalArticle

22 Scopus citations